MONTRAL, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Elixxer Ltd. (TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (“ Elixxer ” or the “ Company ”) is pleased to share the latest achievements of its largest holding Little Green Pharma Ltd. (LGP). LGP has achieved the following major milestones that are validating our investment:
- Fulfilment of CC Pharma order to Germany (2,400 bottles) or $600,000 AUD order value.
- Partnership with national health insurer that now allows LGP oils to be reimbursed by insurance, now patients can get their much-needed medicine from LGP without worrying about out-of-pocket expenses.
- Grant of the Australian Department of Health, Therapeutic Goods Administration (TGA) GMP manufacturing licence by the Office of Drug Control (ODC) and commissioning of new facility this allows for higher volume production to satisfy the order flow.
- Successful first harvest and capacity increase in expanded new facility.
- First commercial quantity delivered to the UK.
- https://stockhouse.com/news/press-releases/2020/12/01/little-green-pharma-holding-exceeds-15m-in-value-for-elixxer
-